Log in to save to my catalogue

Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor...

Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c47a0b935486445aafab933f5d652620

Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

Publication information

Publisher

London: Nature Publishing Group UK

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c47a0b935486445aafab933f5d652620

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c47a0b935486445aafab933f5d652620

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-34580-3

How to access this item